Sign in
Clinical Course and Outcomes at 3 Years After Severe Fungal Endophthalmitis in 14 Eyes Following Contaminated Bevacizumab Intravitreal Injection
Mallika Goyal, MD
Annual Meeting Talks
2018
Board-Certified Providers Are Associated With a Reduced Risk of Endophthalmitis After Intravitreal Injections
Geoffrey G. Emerson, MD, PhD, FASRS
Updates from the Field
2021
2 Real-World Analyses of Treatment Burden Associated With Intravitreal Injections for DME Prior to 0.2 mcg/Day Fluocinolone Acetonide (FAc)
Nancy M. Holekamp, MD, FASRS
Category: Instrumentation and Devices